Skip to main content
Veterinary Medicines

ECTOLINE DUO 402 MG/120 MG SPOT-ON SOLUTION FOR VERY LARGE DOGS

Authorised
This information is not available for this product.

Product identification

Medicine name:
ECTOLINE DUO 402 MG/120 MG SPOT-ON SOLUTION FOR VERY LARGE DOGS
Flea Free Combo 402 mg/120 mg spot-on oplossing voor extra grote honden
Active substance:
This information is not available for this product.
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • Box containing 1 pipette of 4.02 mL
  • Box containing 2 pipettes of 4.02 mL
  • Box containing 3 pipettes of 4.02 mL
  • Box containing 4 pipettes of 4.02 mL
  • Box containing 6 pipettes of 4.02 mL

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 116242
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0404/004
Concerned member states:
  • Italy
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 9/04/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."